[Emicizumab (haemophilia A) - Addendum to Commission A18-20]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003437
German
Original Title:
Emicizumab (Haemophilie A) - Addendum zum Auftrag A18-20
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a18-49.html
Year Published:
2018
URL for published report:
https://www.iqwig.de/download/A18-49_Emicizumab_Addendum-zum-Auftrag-A18-20_V1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Hemophilia A
- Antibodies, Monoclonal, Humanized
- Antibodies, Bispecific
- Blood Coagulation Factors
- Factor VIII
Keywords
- Emicizumab
- Hemophilia A
- Benefit Assessment
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.